Summary of clinical results

DUCRAY
SPRAY SOS

Clinical study on the safety and efficacy of SENSINOL Spray SOS

Dermatologically-controlled clinical study of the safety and efficacy of SENSINOL Spray SOS in adults with sensitive scalps.

Population

35 subjects included.

77% women/23% men (20 - 66 years) with a sensitive scalp:

3S score > 2 

Application of SENSINOL Spray SOS

At least 1 application a day for the1st week, then 3 times a week for the following 2 weeks.

Evaluation criteria

  • Scoring by the subject : 
    o Self-assessment questionnaire on the impact of 5 sensations (itching, tingling, pulling, pain, burning) on quality of life (3S Score) 
    o Self-assessment of intensity of burning, pain, xerosis and scalp comfort (visual analog scale from 0 to 10) 
    o Cosmetic acceptability questionnaire
  • Skin tolerance 
     

Results

Immediate action: highly significant reduction in intensity score of burning sensations, pain, xerosis andscalp comfort after the1st application (p < 0.001 vs. D1).

 

Evolution of the intensity score of burning sensations, pain, xerosis and scalp comfort (VAS 0-10) after the first application (D1 Timm)

photo 1 sensinol

Intensification of effect after 21-day treatment: highly significant reduction in intensity score of burning sensations, pain, xerosis and scalp comfort(p < 0.001 vs D1).

 

Evolution of the intensity score of burning sensations, pain, xerosis and scalp comfort (VAS 0-10) after the 21-day treatment phase

photo 2 sensinol

Highly significant reduction in the impact of scalp pruritus on quality of lifeafter 21 days of treatment : overall 3S score reduced by 78% at D22 (p < 0.001 vs. D1).

 

Evolution of the 3S score during the 21-day treatment phase

Image 3

Very good cosmetic acceptability after 21 days of treatment.

100% of subjects appreciated the non-greasy texture of the product applied to the scalp.

Excellent skin tolerance.

 

Conclusion

SENSINOL Spray SOS : soothing effect on the scalp from the1st application. Significant improvement in quality of life associated with scalp pruritus after 3 weeks of treatment.

More summaries of clinical results